Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')2 fragments. (2023)
Attributed to:
Development of an ovine polyclonal immunoglobulin therapy against COVID-19.
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-023-40277-4
PubMed Identifier: 37626085
Publication URI: http://europepmc.org/abstract/MED/37626085
Type: Journal Article/Review
Volume: 13
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322